Navigation Links
AstraZeneca Submits New Drug Applications for ZACTIMA(TM) in Second-Line Advanced Non-Small Cell Lung Cancer
Date:7/30/2009

WILMINGTON, Del., July 30 /PRNewswire-FirstCall/ -- AstraZeneca (NYSE: AZN) today announced the company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) and a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMEA) for an investigational drug, vandetanib 100 mg for use in combination with chemotherapy for the treatment of advanced non-small cell lung cancer in patients previously treated with one prior anti-cancer therapy. The U.S. and European submissions are supported by data from Phase III clinical studies evaluating the safety and efficacy of vandetanib 100 mg in combination with chemotherapy. Pending approval, the treatment will be marketed as ZACTIMA(TM).

Evaluation of vandetanib is ongoing, as monotherapy or in combination with other anti-cancer therapies in a range of tumour types, including thyroid cancer. Results from the ZEPHYR (300mg monotherapy study in EGFR failures in advanced NSCLC, Phase III) and ZETA (300 mg monotherapy in advanced medullary thyroid cancer, Phase III) studies will be presented in the first half of 2010.

Howard Hutchinson, MD, Chief Medical Officer at AstraZeneca said, "Lung cancer is an area of high unmet need and these submissions are an important step toward potentially broadening the treatment options available for patients."

About Vandetanib

Vandetanib has a unique profile that fights cancer through two clinically proven mechanisms -- by blocking the development of tumour blood supply (anti-angiogenesis or anti-VEGFR), and by blocking the growth and survival of the tumour itself (anti-EGFR). Vandetanib also inhibits RET-tyrosine kinase activity, an important growth driver in certain types of thyroid cancer.

About Vandetanib Phase III Studies'/>"/>

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. AstraZeneca Leads Local Walking Movement
2. AstraZeneca Joins Local Walking Movement
3. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
4. Verus Pharmaceuticals Announces Divestiture of Pediatric Asthma Development Programs to AstraZeneca
5. AstraZeneca Recognized as One of Working Mothers 100 Best Companies for the Sixth Consecutive Year
6. AstraZeneca Launches New Program to Support Facilities that Connect People to Needed Medical Care and Prescription Assistance
7. NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for $30 Million to Support Late-Stage Product Development
8. Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca
9. Perrigo Announces that Dexcels Settlement with AstraZeneca Allows OTC Omeprazole Launch Following Final FDA Approval
10. AstraZeneca Response to November 2, 2007 Ruling In Re: Pharmaceutical Industry Average Wholesale Price Litigation, MDL No. 1456, U.S. District Court, District of Massachusetts
11. AstraZeneca Receives Six Months Pediatric Exclusivity Patent Extension for ARIMIDEX(R) (anastrozole) from the FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... OR (PRWEB) April 27, 2015 Doping ... as Lance Armstrong and Alex Rodriguez continue to capture ... neurology present a new frontier in performance enhancement along ... SCI TV , accomplished neuroscientist Anjan Chatterjee ... talks about the ethics and dangers of these enhancements ...
(Date:4/27/2015)... Launched by a group of ... consumers a way to connect to top local ... a patent-pending Pick Your Price matching algorithm, clients ... laser hair removal and dermal fillers on days ... in their schedules. This allows clients to take ...
(Date:4/26/2015)... NC (PRWEB) April 26, 2015 Italian ... the deadly legacy of asbestos cement plants and other ... on the new research. Click here to read ... from Italy’s Department of Occupational and Environmental Medicine analyzed ... 2008 and found 32 clusters where the asbestos cancer ...
(Date:4/26/2015)... From March 18th, 2015 toward the middle of ... Trivedi, spent a month traveling in India to find ... the efforts of creating highly advanced, effective and less ... health care. , During their journey, they met ... lab facilities are approved by the U.S. Food and ...
(Date:4/26/2015)... April 26, 2015 In an article ... University evaluated the head-neck biomechanics occurring during the use of ... were able to determine that use of a tablet increases ... to 5 times - more than when the neck is ... such a study, but pointing out the potential hazards of ...
Breaking Medicine News(10 mins):Health News:The Brain, Smart Drugs, and Sports on SCI TV with Anjan Chatterjee 2Health News:The Brain, Smart Drugs, and Sports on SCI TV with Anjan Chatterjee 3Health News:ZendyBeauty Is Pleased to Announce the Expansion and Rebranding of the Company as ZendyHealth.com 2Health News:New Investigation Finds Mesothelioma “Clusters” Around Italian Cement Plants, According to Surviving Mesothelioma 2Health News:Trivedi Science™ Has Started Scientific Research to Create More Effective Pharmaceuticals and Nutraceuticals 2Health News:Trivedi Science™ Has Started Scientific Research to Create More Effective Pharmaceuticals and Nutraceuticals 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 2Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 3Health News:Avoiding the Pain in the Neck Caused by Overuse of Technology 4
... study by a researcher at Karolinska Institutet in Sweden ... brain cells . ,The finding also helps ... ,Previous research had shown that exercise has similar effect ... found that this process happens as exercise stimulates the ...
... revealed that the secret of his relatively wrinkle-free visage at the ... ,The slender rock star, notorious for his wild ... applies a special cream under his eyes in order to keep ... the Daily Express quotes him as saying. ,"I ...
... (WFP) today announced plans to assist the Government of Timor-Leste ... communities affected by an ongoing drought. ,"There is ... the drought, and we will work closely with the Government ... said Tarek Elguindi, WFP Representative in Dili, Timor Leste. ...
... has announced a funding of 102 million pounds (Rs.816 ... phase of Government of India's (GOIs) National AIDS Control Programme ... comprehensive prevention, care and support programme to halt and begin ... announcement was made by Susanna Moorehead, Head of DFID India ...
... Wiliam's ex-girlfriend Kate Middleton's curvaceous figure has suddenly gone too ... style for her slender but athletic figure, is donning a ... appearances Kate appeared painfully thin, bony and almost flat chested. ... loss is due to the strain following her split with ...
... Klass has followed in the footsteps of actress Demi Moore, by ... Celebrity star, wearing only her engagement ring and a butterfly necklace, ... think, 'Does my belly or my bum look big'. You just ... saying. ,"And the shoot was great fun. They had ...
Cached Medicine News:
(Date:4/26/2015)... BARCELONA , April 26, 2015 Cancer ... VAR ) supported project in the area of ... "big data" for the benefit of patients. Speakers at ... (European Society for Therapeutic Radiation Oncology) forum in Barcelona ... each treatment and applying that knowledge to help benefit ...
(Date:4/24/2015)... YORK , April 24, 2015   ... Aerie Pharmaceuticals, Inc. ("Aerie" or the "Company") (NASDAQ: ... statements to investors in violation of the federal ... of Aerie breached their fiduciary duties to shareholders. ... focused on the discovery, development and commercialization of ...
(Date:4/24/2015)... N.J. , April 24, 2015  IGI Laboratories, ... based specialty generic pharmaceutical company, announced the ... ET on Tuesday, April 28, 2015 to discuss the ... you to listen to the call by dialing 1-888-346-3479. ... 1-855-669-9657.  Participants should ask to be joined into the ...
Breaking Medicine Technology:Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum 2Cancer Experts Detail How 'Big Data' Plays a Critical Role in Improving Clinical Decision-Making in Oncology Treatments at 3rd ESTRO Forum 3Bernstein Liebhard LLP Investigates Claims On Behalf Of Those Who Invested In Aerie Pharmaceuticals, Inc. 2
... Dec. 2, 2010 BugLab LLC, the industry leader ... – the world,s first handheld sensor for measuring optical ... device removes the need to open shake flasks to ... through the container wall, the labor, contamination risk, and ...
... 2010 SeQual Technologies, Inc., a pioneer in portable ... be acquired by Chart Industries, wholly owned subsidiary, CAIRE ... home health care market. SeQual has built a strong ... focus. As a leader in portable oxygen concentrators, SeQual ...
Cached Medicine Technology:BugLab Launches World's First Handheld Non-invasive Optical Density Sensor 2SeQual Technologies to be Acquired by Chart Industries 2
... The Surgifoam* absorbable gelatin sponge, U.S.P. ... gelatin absorbable sponge intended for hemostatic ... surface. The sponge is off-white and ... speed to hemostasis, highly favorable surgeon ...
12 mm diameter pigtail curved probes with eyes 4mm back of blunt ends. Stainless steel. Round knurled handle with polished finish. Overall length: 5.9 inches....
The Meridian Microruptor V Nd: YAG laser system is indicated for posterior capsulotomy, peripheral iridotomy, and pupillary membranectomy procedures....
... method for determining color vision abnormalities and ... can be applied to many psychological and ... of four trays containing a total of ... incremental hue variation on one side and ...
Medicine Products: